Paper198216
Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats.
Vollmer RR and 1 other. Eur J Pharmacol, 1977. Cited by 83 papers, by iCite.
Cite this record
ConductScience Library. Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats. Papers, record 198216. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/198216
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin-Converting Enzyme Inhibitors | Major topic |
| Hemodynamics | Major topic |
| Proline | Major topic |
| Angiotensin I | |
| Angiotensin II | |
| Animals | |
| Blood Pressure | |
| Brain | |
| Cats | |
| Female | |
| Heart Rate | |
| Injections, Intravenous | |
| Injections, Intraventricular | |
| Male | |
| Time Factors |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7009133 | Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. | Drugs | 1980 | https://conductscience.org/library/papers/7009133 | PubMed |
| 6997332 | Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. | J Clin Invest | 1980 | https://conductscience.org/library/papers/6997332 | PubMed |
| 3154307 | Preclinical studies on angiotensin converting enzyme inhibitors. | Cardiovasc Drugs Ther | 1987 | https://conductscience.org/library/papers/3154307 | PubMed |
| 2994989 | Enalapril maleate versus captopril. A comparison of the hormonal and antihypertensive effects. | Drugs | 1985 | https://conductscience.org/library/papers/2994989 | PubMed |
| 1857115 | Continuous measurement of renal cortical blood flow and renal arterial blood flow during stimulation of the renal nerve. | Med Biol Eng Comput | 1991 | https://conductscience.org/library/papers/1857115 | PubMed |
| 575417 | Blockade of pressor responses to angiotensins I and II and noradrenaline using phentolamine, propranolol and hexamethonium in conscious rabbits. | Pflugers Arch | 1979 | https://conductscience.org/library/papers/575417 | PubMed |
| 465290 | Influence of various antihypertensive agents on lifespan of renal hypertensive rats. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/465290 | PubMed |
| 223614 | Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/223614 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/198216
GET https://conductscience.org/api/papers/v1/198216/authors